What happens to cartilage at the moment of an ACL tear

The damage to cartilage begins in the same moment the ligament tears — not months later, not at the first sign of swelling. When the knee buckles under the forces of a twist, pivot, or collision, the femur and tibia are driven violently together, compressing the joint surfaces with enough force to bruise the underlying bone of the femoral condyle and tibial plateau. This bone bruising is visible on MRI within days of injury and marks where the cartilage above it has already taken its first structural blow.

Beneath the surface, that same compressive shock causes micro-cracking in the deep layers of articular cartilage and kills chondrocytes — the cells responsible for maintaining cartilage structure — at the point of impact. These cells cannot be replaced. Articular cartilage has no blood supply, so it cannot mount the repair response that skin, bone, or muscle can. Damaged matrix stays damaged; dead chondrocytes stay absent.

This is the part of an ACL injury that often surprises patients: some cartilage harm is already done before they leave the pitch, before they see a doctor, and entirely independently of whether they go on to have surgery or not. Reconstruction addresses instability; it cannot undo what occurred in the first fraction of a second.

How instability and time compound the damage

Once that initial trauma has passed, two further processes take over — and unlike the split-second injury, they are measured in weeks and months.

Uneven load on unprotected surfaces

The ACL's job is to stop the tibia sliding forward beneath the femur during movement. Without it, every step, stair, and change of direction allows a small but repeated abnormal shift in joint alignment. Think of a car tyre that has lost its tread pattern on one edge — the wear accelerates precisely because the load is no longer distributed evenly. In the ACL-deficient knee, body weight is redirected onto cartilage zones that are not built for concentrated stress, and that erosion is cumulative. Concomitant meniscal tears — present in a significant proportion of ACL injuries — compound this considerably. The menisci act as the joint's primary shock absorbers and load distributors; once torn, the friction on the remaining cartilage multiplies further. Evidence from the MOON Nested Cohort confirms that patients who required meniscal treatment at the time of reconstruction showed significantly worse cartilage damage on MRI at two to three years post-surgery.

The biochemical storm that continues silently

The torn ligament also releases inflammatory proteins directly into the synovial fluid. These activate matrix metalloproteinases (MMPs) — enzymes that degrade the extracellular matrix of articular cartilage. Because cartilage is avascular, it has no mechanism to clear these enzymes or rebuild what they destroy. This process requires no mechanical load to proceed; it continues whether the patient is active or resting.

All three pathways — the acute structural injury described earlier, abnormal mechanical loading, and the biochemical cascade — operate simultaneously and reinforce one another. Delay is not neutral.

How often post-traumatic OA actually develops — and what reconstruction changes

A 2023 Bone & Joint Journal meta-analysis of studies with at least ten years of follow-up places pooled post-traumatic OA prevalence at 37.9% for operatively treated ACL injuries and 40.5% for non-operatively treated ones — and those rates have barely shifted despite decades of surgical advances. At fourteen years, 57% of patients who underwent ACL reconstruction show radiographic knee OA compared with 18% in the contralateral, uninjured knee: more than three times the rate in a joint that never tore.

The figure that perhaps best illustrates the gap between felt stability and structural reality comes from the 2026 SUPER-Knee Trial. In 184 symptomatic young adults with a mean age of 30, scanned just 9–36 months after reconstruction, 61% already had tibiofemoral cartilage loss on MRI and 39% met the full imaging criteria for OA — in a group that, by conventional functional measures, was doing reasonably well post-surgery. Damage was accumulating silently.

Reconstruction is not futile — it reliably restores joint stability, reduces further instability episodes, and limits the secondary meniscal damage that compounds cartilage wear. But published evidence does not support the conclusion that it arrests the degenerative cascade initiated at the moment of injury. The cartilage micro-damage, the chondrocyte loss, and the biochemical environment described in the preceding sections persist regardless of whether a graft is placed.

No current treatment has been shown to prevent PTOA after an ACL tear. That is not a reason for pessimism — it is the precise reason why surgical success alone is an insufficient outcome target. What it points towards is a monitoring-led approach: tracking cartilage health actively, rather than waiting for symptomatic thresholds that may not arrive until structural damage is advanced.

When to seek specialist assessment — and why timing creates a window

The intervention window is real but finite. T1ρ and T2 quantitative MRI sequences — mapping proteoglycan content and collagen structure respectively — can detect early biochemical cartilage changes at just one year after reconstruction, and those findings correlate with whole-joint OA severity at ten years. That gap between detectable change and irreversible structural damage is where specialist assessment has most to offer.

Working backwards, the case for early referral is strongest in identifiable groups. In patients aged 40 and over, patellofemoral cartilage damage present at the time of ACL reconstruction independently predicts poor one-year outcomes across all KOOS subscores — pain, daily activities, sport, and quality of life — making pre-surgical cartilage mapping particularly urgent in this age group. A confirmed or suspected meniscal tear adds further urgency: meniscal treatment at reconstruction independently predicts worse cartilage damage on MRI at two to three years.

Broader clinical practice recognises an earlier threshold. Referral from age 35 is prudent because, while the specific outcomes data linking patellofemoral cartilage damage to poor functional scores applies to patients aged 40 and over, the combination of increasing biological age and sustained activity demands begins to influence cartilage trajectory somewhat earlier. The two figures are not contradictory — 40 marks the evidence-based outcome inflection point; 35 reflects a wider clinical consensus for proactive assessment before that risk is fully realised.

Crucially, the SUPER-Knee Trial data showed no significant correlation between MRI-defined OA features and formal clinical classification criteria — meaning many patients with meaningful structural changes are not yet categorised as having OA by conventional measures. Waiting for symptoms to worsen is not a safe holding strategy.

Flags suggesting early specialist review:

• Age 35 or above at time of injury
• Confirmed or suspected meniscal involvement
• High-energy or contact injury mechanism
• Persistent joint swelling or giving-way episodes
• Any athlete planning return to pivoting or cutting sport

What a cartilage-focused specialist assessment involves

Arriving at a cartilage-focused consultation after an ACL tear, the first thing that becomes clear is that the assessment is asking a materially different question from a standard GP referral — not just "is the ligament torn?" but "how much of the joint has already changed, and what are the realistic options for protecting what remains?"

Physical examination begins with instability quantification. The Lachman test — applied in approximately 20–30° of knee flexion — measures anterior tibial translation, while the pivot-shift test replicates the rotational give-away that patients describe on stairs or uneven ground. A KT-1000 or KT-2000 arthrometer converts those clinical impressions into an objective millimetre measurement of laxity, establishing a baseline against which any future change can be tracked.

Standard MRI then reads simultaneously for bone bruising, meniscal integrity, and cartilage thinning. One finding that immediately alters operative planning is cartilage damage in the patellofemoral compartment: in patients aged 40 and over, its presence at surgery independently predicts worse outcomes at one year across every KOOS subscore — pain, daily activities, sport, and quality of life — so identifying it before the operating theatre directly shapes both surgical technique and rehabilitation expectations.

Where quantitative T1ρ and T2 mapping sequences are available — not standard at every centre, which is part of what distinguishes a specialist assessment — the picture sharpens further. These sequences map proteoglycan content and collagen structure in cartilage that may still appear intact on conventional imaging, and changes detected at one year post-reconstruction correlate with whole-joint OA severity at ten years. When intraoperative assessment follows, Outerbridge grading classifies cartilage on a four-point scale: from surface softening (Grade 1) through partial- and full-thickness loss to bone exposure (Grade 4), each grade pointing toward a different repair strategy.

The output is not a binary reconstruct-or-don't decision. It is a stratified map of instability severity, cartilage status, meniscal integrity, and alignment — from which a personalised preservation plan can be constructed.

Cartilage preservation options after ACL injury

Treatment decisions here track directly from what assessment finds. The right intervention for Grade 1 cartilage softening in a recreational runner differs fundamentally from a Grade 3 full-thickness defect in a 42-year-old preparing to return to football — and the approach is sequential rather than a simultaneous menu.

At early or low-grade involvement, conservative management — NSAIDs, targeted physiotherapy, and activity modification — remains appropriate and may protect the joint adequately while reconstruction is planned or recovery is monitored.

Where focal defects require surgical attention, options escalate by defect size and tissue-quality goals. Arthroscopic débridement offers short-term symptom relief. Microfracture addresses small focal lesions by stimulating fibrocartilage fill, though fibrocartilage has lower long-term durability than native hyaline cartilage. For larger defects, osteochondral autograft transplantation (OAT) and osteochondral allograft transplantation (OCA) restore genuine hyaline cartilage and, in appropriately selected patients, are associated with superior return-to-sport outcomes. Autologous chondrocyte implantation (ACI) and its matrix-assisted variant (MACI), combined with ACL reconstruction, represent a cell-based route for significant focal lesions identified at the time of surgery.

Emerging approaches — notably bridge-enhanced ACL repair, which aims to preserve remnant ligament biology — have produced less macroscopic cartilage damage than conventional reconstruction in preclinical porcine models. They are investigational, not yet standard clinical practice.

For patients at or approaching this decision point, a cartilage-focused specialist assessment — available at London Cartilage Clinic, Harley Street — provides the imaging-led evaluation needed to map where on this pathway their joint sits. The broader lesson of the evidence, however, is the harder one: no treatment currently reverses a joint to its pre-injury state. Acting early, while the preservation window remains open, is the most reliable strategy the evidence currently supports.

1. [1] Prevalence of post-traumatic osteoarthritis after ACL injury remains high despite advances in surgical techniques. (2023). https://doi.org/10.1302/0301-620X.105B11.BJJ-2023-0058.R1 https://doi.org/10.1302/0301-620X.105B11.BJJ-2023-0058.R1
2. [2] Knee Osteoarthritis on MRI in Symptomatic Young Adults After ACL Reconstruction From the SUPER-Knee Trial. (2026). https://doi.org/10.1177/23259671261455852 https://doi.org/10.1177/23259671261455852
3. [3] Quantitative MRI of Medial Tibial Cartilage at One Year After ACL Reconstruction Can Predict PTOA at 10 Years. (2025). https://doi.org/10.1177/2325967125S00296 https://doi.org/10.1177/2325967125S00296
4. [4] Articular Cartilage Damage in the Patellofemoral Compartment at ACL Reconstruction Predicts Poor Postoperative Subjective Outcomes in Patients Age 40 and Older. (2023). https://doi.org/10.1055/a-2368-3739 https://doi.org/10.1055/a-2368-3739
5. [5] Is meniscus treatment a predictor of worse articular cartilage damage on MRI 2 years after ACL reconstruction? The MOON Nested Cohort. (2022). https://doi.org/10.1177/03635465221074662 https://doi.org/10.1177/03635465221074662
6. [6] Bridge-Enhanced ACL Repair Leads to Greater Offloading of the Surgical Knee and Less Cartilage Damage in the Porcine ACL Transection Model. (2021). https://doi.org/10.1177/0363546521989265 https://doi.org/10.1177/0363546521989265
7. [7] Treatment options for concomitant cartilage damage in the ACL-injured athlete. (2026). https://doi.org/10.21037/aoj-2025-1-75 https://doi.org/10.21037/aoj-2025-1-75